Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70

Reuters

06/26

Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70

Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2546221316"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546221316\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546221316?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 06:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546221316","market":"fut","top_or_hot":-1,"title":"Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-26 06:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KEQU","symbol_name":"基瓦尼科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDLbVqJxC:1","article_id":"2546221316","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546221316","pubTimestamp":1750890188,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"KEQU":"基瓦尼科技"},"translate_title":"Kewaunee Scientific报告2025财年销售额增长18%；每股净利润跃升至1.70美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KEQU":0.9},"content_text":"Kewaunee Scientific Reports 18% Increase in FY 2025 Sales; Net Earnings Per Share Jump to $1.70\n    \n\n        Kewaunee Scientific Corporation reported strong financial results for fiscal year 2025, with sales reaching $240.5 million, marking an 18.0% increase compared to $203.8 million in the previous year. The company's net earnings for the year were $4.9 million, up from $4.6 million in the prior period. Operating profit saw a notable improvement, with $23.5 million recorded for fiscal 2025 compared to $18.3 million in the previous year. Earnings per share for the quarter ending April 30, 2024, showed positive results, with basic EPS at $1.70 for domestic operations and $0.34 for international operations. Kewaunee Scientific's President and CEO, Thomas D. Hull, III, highlighted the company's momentum in the market and its strategy of investing in the product portfolio and manufacturing assets. The company continues to focus on strengthening their dealer and distribution relationships, which has been a key driver for performance improvement. No specific guidance or outlook for the future was provided in the report.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kewaunee Scientific Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL18552) on June 25, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}